Dina Baier

3PUBLICATIONS

24CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 06, 2025

Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.

Alexander Rosner, Lukas Skos, Theresa Mendrina

|Feb 25, 2023

Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands.

Theresa Mendrina, Isabella Poetsch, Hemma Schueffl

|Nov 26, 2022

Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib.

Bahil Ghanim, Dina Baier, Christine Pirker

Pageof 1

Frequent Collaborators

3 joint publications

Walter Berger

2 joint publications

Petra Heffeter

1 joint publications

Bahil Ghanim

1 joint publications

Leonhard Müllauer

1 joint publications

Katharina Sinn

1 joint publications

Gyoergy Lang

1 joint publications

Hemma Schueffl

1 joint publications

Alexander Ries

1 joint publications

Christian R Kowol

1 joint publications

Michael Grusch

Frequent Collaborators

3 joint publications

Walter Berger

2 joint publications

Petra Heffeter

1 joint publications

Bahil Ghanim

1 joint publications

Leonhard Müllauer